Spyre Therapeutics
Spyre Therapeutics Logo
About Spyre Therapeutics
Spyre Therapeutics Inc is a biotechnology company focused on developing antibody-based therapeutics and precision immunology approaches for inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, as well as other immune-mediated diseases. Its pipeline includes preclinical-stage monoclonal antibodies such as SPY001, SPY002, and combination therapies like SPY120, SPY130, and SPY230, targeting key pathways involved in chronic inflammation. The company aims to create rational therapeutic combinations to improve efficacy and convenience for patients.
Address
221 Crescent Street, Building 23 Suite 105
Waltham, 02453
United States
Year founded
2013
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
